Newark ::
NJ ::
USA
| updated 2013-06-11 06:42:11 -0700
| business-news
A former Bristol-Myers Squibb executive pleaded guilty to insider trading for buying stock options in three drugmakers that were targeted for acquisition, which yielded more than $311,000 in profits. Robert Ramnarine, 46, a former executive director of pension and savings,...